Key result
DNA-analysis with flanking and intragenic markers yielded confusing results regarding carriership in 9.5% (7 of 74) of Finnish families with Duchenne or Becker muscular dystrophy.
Observational (n=74)
Genetic counselling for Duchenne and Becker muscular dystrophy remains problematic in a subset of families due to conflicting DNA and biochemical marker results.
Conflicting DNA-biochemical results may complicate DMD/BMD carriership counseling; this case report leaves open integrated testing strategies.
DNA-analysis with flanking and intragenic markers gave confusing results in 7 out of 74 (9.5%) Finnish families with Duchenne or Becker muscular dystrophy. In five families a sister or maternal aunt of the patient had elevated serum creatine kinase (CK) activity, although DNA-analysis indicated a low risk for carriership. In one family the two affected brothers had different pERT87 alleles. In one family the intragenic deletion found in a patient was not present in his mother, who was an obligatory carrier. Deletions were detected with cDNA probes in the probands in five of the families, but the controversy regarding carriership still remained. It is necessary to combine all available data from pedigree analysis, CK measurements, and DNA studies whenever carrier studies are performed, but it appears that major problems in counselling and prenatal diagnosis will still remain in a proportion of the families.
No takes yet. Share an insight, caveat, or question.
Kääriäinen et al. (1990) conducted an observational in Duchenne or Becker muscular dystrophy (n=74). DNA-analysis with flanking and intragenic markers was evaluated on Confusing results in carrier studies. DNA-analysis with flanking and intragenic markers yielded confusing results regarding carriership in 9.5% (7 of 74) of Finnish families with Duchenne or Becker muscular dystrophy.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: